Correction to: Cytotechnology (2021) 73:473–482 https://doi.org/10.1007/s10616-021-00471-6


In Figs. 3 and 6 of this article, the results of transwell experiment were not very ideal and the data organization problem caused some confusion in the inter group data.

Figures 3 and 6 should have appeared as shown below. The original article has been corrected.

Fig. 3
figure 3

NNT-AS1 promotes metastasis of glioma cells in vitro. a Transwell migration and invasion assays show that NNT-AS1 knockdown suppressed cell migration and invasion ability (magnification × 200). b, c Expression of E-cadherin and N-cadherin were examined via RT-qPCR and western blot in both U87MG and A172 cells. * P < 0.05, **P < 0.01 vs. sh-NC group

Full size image
Fig. 6
figure 6

Knockdown of NNT-AS1 expression inhibits glioma progression via miR-582-5p/EZH2 axis. a The RT-qPCR assay was implemented to certify transfection efficiency for miR-582- 5p inhibitor and sh-EZH2. b–d CCK-8, EdU, transwell assays were employed to estimate the role of NNT-AS1/miR-582-5p/ EZH2 axis in U87MG cell proliferation, migration and invasion (magnification × 200). e, f RT-qPCR and western blot analyses were performed to detected mRNA and protein expressions of E-cadherin and N-cadherin. **P < 0.01 vs. inhibitor-NC, #P < 0.05, ##P < 0.01 vs. smiR-582-5p inhibitor

Full size image